Use of Persantine in preventing thromboembolism following valve replacement.
D000293:Adolescent; D000328:Adult; D001021:Aortic Valve / Q000601:surgery*; D001792:Blood Platelets; D004176:Dipyridamole / Q000627:therapeutic use*; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery*; D010973:Platelet Adhesiveness / Q000187:drug effects; D011183:Postoperative Complications / Q000517:prevention & control; D013923:Thromboembolism / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
D014859:Warfarin; D004176:Dipyridamole